Medicare Part D coverage · lanthanum carbonate · RxCUI 642452
lanthanum carbonate 750 MG Chewable Tablet
Per the CMS 2026 Part D formulary file, lanthanum carbonate 750 MG Chewable Tablet is covered by 240 Medicare Part D plans (4.8% of enrollable products), averaging Tier 3, with prior authorization required on 8.3% of covering formularies.
- 4.8%
- Plan coverage
- 240
- Plans covering
- T3
- Avg tier
- 8.3%
- Prior auth required
What the CMS Formulary Data Shows for lanthanum carbonate 750 MG Chewable Tablet
Per the CMS 2026 Part D formulary file, lanthanum carbonate 750 MG Chewable Tablet (RxNorm concept RXCUI 642452, generic name lanthanum carbonate) appears on 36 distinct formulary files spanning 240 Medicare Part D plan offerings - 4.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.
Real-world access to lanthanum carbonate 750 MG Chewable Tablet depends on utilization management as much as tier placement: 8.3% of covering formularies require prior authorization. 0% require step therapy. 8.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 13,966 Part D beneficiaries filled lanthanum carbonate 750 MG Chewable Tablet in 2023, with total plan-and-beneficiary spending of $58,352,402 and an average per-beneficiary annual cost of $4,178.18. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry lanthanum carbonate 750 MG Chewable Tablet today.
Coverage Details
- Formularies covering
- 36
- Plans covering
- 240
- Coverage rate
- 4.8%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 8.3% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 8.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 13,966
- Total spending
- $58,352,402
- Avg per beneficiary
- $4,178.18
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering lanthanum carbonate 750 MG Chewable Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | No | $0 | CA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | No | $4.80 | FL |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Arizona | T1 | No | $17.00 | AZ |
| Troy Medicare (HMO) | Troy Health, Inc. | T2 | No | $0 | NC |
| Troy Medicare for Dual-eligible Beneficiaries (HMO D-SNP) | Troy Health, Inc. | T2 | No | $0 | NC |
| Contra Costa Health Care Plus (HMO D-SNP) | Contra Costa County Medical Service DBA Contra Costa Health | T2 | No | $0 | CA |
| Keystone First VIP Choice (HMO D-SNP) | Vista Health Plan, Inc. | T2 | No | $0 | PA |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Vista Health Plan, Inc. | T2 | No | $0 | PA |
| First Choice VIP Care (HMO D-SNP) | Select Health OF South Carolina, Inc. | T2 | No | $0 | SC |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | AmeriHealth Caritas VIP Next, Inc. | T2 | No | $0 | DE |
| AmeriHealth Caritas VIP Care Choice (HMO D-SNP) | AmeriHealth Caritas VIP Next, Inc. | T2 | No | $0 | DE |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas Florida, Inc. | T2 | No | $0 | FL |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas Louisiana, Inc. | T2 | No | $0 | LA |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas North Carolina, Inc. | T2 | No | $0 | NC |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Michigan, Inc. | T2 | No | $0 | MI |
| Healthy Mississippi Premier Advantage (HMO-POS) | Healthy Mississippi, Inc. | T2 | No | $0 | MS |
Show the next 30 plans
| Prominence Plus (HMO) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Plus (HMO) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Giveback (HMO) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Plus (HMO) | Prominence Healthfirst OF Florida Inc | T2 | No | $0 | FL |
| Prominence Giveback (HMO) | Prominence Healthfirst OF Florida Inc | T2 | No | $0 | FL |
| Prominence Plus (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Plus (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Extra Help (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Beyond (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Giveback (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Giveback (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Beyond (HMO-POS) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst OF Florida Inc | T2 | No | $0 | FL |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | Prominence Healthfirst OF Florida Inc | T2 | No | $0 | FL |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Diabetes and Heart Care Plus (HMO C-SNP) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Extra Help (HMO) | Prominence Healthfirst | T2 | No | $4.20 | NV |
| Prominence Extra Help (HMO) | Prominence Healthfirst OF Florida Inc | T2 | No | $4.80 | FL |
| Prominence Extra Help (HMO) | Prominence Healthfirst OF Texas | T2 | No | $4.80 | TX |
| Prominence Extra Help (HMO) | Prominence Healthfirst | T2 | No | $9.50 | NV |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T4 | No | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T4 | No | $0 | NV |
| Select Health Medicare Dual (HMO D-SNP) | Selecthealth, Inc. | T4 | No | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T4 | No | $0 | UT |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is lanthanum carbonate 750 MG Chewable Tablet covered by Medicare Part D?
Yes, lanthanum carbonate 750 MG Chewable Tablet is covered by 240 Medicare Part D plans (4.8% of all Part D formularies).
What tier is lanthanum carbonate 750 MG Chewable Tablet on Medicare Part D plans?
lanthanum carbonate 750 MG Chewable Tablet averages Tier 3 across Part D plans, ranging from Tier 1 to Tier 5.
Does lanthanum carbonate 750 MG Chewable Tablet require prior authorization?
8.3% of Part D formularies require prior authorization for lanthanum carbonate 750 MG Chewable Tablet. Step therapy: 0%. Quantity limits: 8.3%.
How much does Medicare spend on lanthanum carbonate 750 MG Chewable Tablet?
In 2023, total Medicare Part D spending on lanthanum carbonate 750 MG Chewable Tablet was $58,352,402, covering 13,966 beneficiaries. The average spend per beneficiary was $4,178.18.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- efinaconazole 100 MG/ML Topical Solution [Jublia] 8.3% PA
- alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet 8.3% PA
- 168 HR estradiol 0.00188 MG/HR / levonorgestrel 0.000625 MG/HR Transdermal System [Climara Pro] 8.3% PA
- prednisolone 30 MG Disintegrating Oral Tablet 8.3% PA
- 100 ML levofloxacin 5 MG/ML Injection 8.3% PA
- estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin] 8.3% PA